Adrian W. Quartel - 06 Dec 2024 Form 3 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Chief Medical Officer
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Adrian W. Quartel
Issuer symbol
ZVRA
Transactions as of
06 Dec 2024
Net transactions value
$0
Form type
3
Filing time
27 Mar 2025, 20:30:21 UTC
Previous filing
16 Mar 2023
Next filing
27 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZVRA Common Stock 2,923 06 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZVRA Stock Option (right to buy) 06 Dec 2024 Common Stock 300,000 $6.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares held in the Issuer's Employee Stock Purchase Plan (the "ESPP"). Total reflects the purchase of 2,923 ESPP shares.
F2 Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney